BioSpace News Archive

The Global Coalition for Adaptive Research (GCAR) announced today that the GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) clinical trial is opening its first clinical site, the Henry Ford Cancer Institute, and will begin enrolling patients this week.

Phoenix, LLC, a Madison, WI nuclear technology company, and SHINE Medical Technologies, a Janesville, WI medical isotope production company, announced completion of a 132-hour test of the high-flux Phoenix neutron generator that will drive SHINE’s medical isotope production system.

MicroMedicine, Inc., a life sciences technology company, today announced that it will be hosting its first Commercial Tutorial at the 34th annual 2019 CYTO Congress of the International Society for Advancement of Cytometry (ISAC) in Vancouver, BC, Canada

SHINE Medical Technologies, a Janesville, WI medical isotope production company, announced the completion of an important milestone validating the SHINE medical isotope production process and business case.

Onlife Health, a national company with 23 years of expertise in delivering comprehensive wellness engagement solutions, and Validic™, the leading provider of health data solutions for remote monitoring and virtual engagement, today announced research demonstrating improved member engagement from the use of wearables and home health devices in wellness programs.

Contrad Swiss, a pharmaceutical company focused on breakthrough, innovative products that reframe the world of medicine, announces a new partnership with Dr JO Serrentino to bring to the market effective biomedical remedies unlike any other.

Physicians Endoscopy, LLC in partnership with University Hospitals Cleveland received successful licensure on May 2, 2019, in the newly developed GI ambulatory surgery center in North Ridgeville, Ohio.

The Massachusetts Medical Society, publisher of the New England Journal of Medicine, today named Eric J. Rubin, MD, PhD, the new editor-in-chief of the Journal and NEJM Group.

Spherix Incorporated (Nasdaq: SPEX) today announced that it has filed a Preliminary Proxy Statement with the Securities and Exchange Commission and announced a Special Meeting of Stockholders related to approving various items related to the proposed and previously announced acquisition of substantially all of the assets of CBM BioPharma, Inc.

Thermo Fisher Scientific announced today that it has entered into a global research collaboration with Predictive Laboratories, a wholly owned subsidiary of Predictive Technology Group, Inc., (OTC PINK: PRED) focused on studying the genetic factors underlying infertility in women.